Anti-Covid nasal spray in approval queue could be game changer for India: Scientist The self-administered nitric oxide spray, developed by Vancouver biotech firm SaNOtize, is said to have yielded promising results in its UK and Canada clinical trials, including against the UK variant. The company is preparing submissions to worldwide regulators for emergency approval. https://ift.tt/eA8V8J
PSUs asked to dedicate hospital beds for Covid-19 management The central ministries have also been advised that details of such dedicated hospital wards or blocks be provided to the public. https://ift.tt/eA8V8J
3rd vax dose likely needed within 12 months: Pfizer CEO Bourla said on Thursday that it is possible people will need to get vaccinated against the coronavirus annually. https://ift.tt/eA8V8J